Clicky

Anatara Lifesciences Ltd  (ANR)

Description: Anatara Lifesciences Ltd is an Australia-based company focused on developing oral solutions for gastrointestinal diseases in production animals and humans and the development and commercialization of Detach, a non-antibiotic therapy that prevents and treats diarrhea (scour) in piglets. Detach is a modified release formulation of BromelainRx, a natural extract from pineapple stems. Detach helps in address the overuse of antibiotics in animals. It is formulated with various ingredients to allow oral administration and delivery to the small intestine. The Company is focused on developing Detach for pigs in Australia and then expanding the program to Europe and the United States. The Company is also developing a similar version of Detach to prevent diarrhea in humans. The Company is seeking to collaborate with pharmaceutical/biotechnology companies for clinical development and commercialization of a similar version of Detach for human application in travelers and military personnel.


Keywords: Medicine Biotechnology Pharmaceutical Gas Disease Travel Antibiotics Sanitation Digestive System Diarrhea Veterinary Medicine Gastrointestinal Tract Military Inr

Home Page: anataralifesciences.com

ANR Technical Analysis

62 Lygon Street
Carlton, VIC 3053
Australia
Phone: 61 3 9824 5454


Officers

Name Title
Dr. David Lionel Brookes FACRRM, FAICD, MBBS Exec. Chairman
Mr. John Michailidis B.Sc., EMBA, M.A.I.C.D. Chief Operations Officer
Jane Lowe Managing Director of IR Department
Mr. Simon Erskine Chief Devel. Officer
Dr. Stephen Denaro AGIA, BCom, CA, GradDipApp CG, MAICD Company Sec.
Ms. Hayley van der Meer B Biomed Sc, Grad Dip Marketing Management Commercial Mang.

Exchange: AU

Country: AU

Currency: Australian Dollar (A$)

Forward PE: 0
Trailing PE: 0
Price-to-Book MRQ: 2.4897
Price-to-Sales TTM: 6.3137
IPO Date:
Fiscal Year End: June
Full Time Employees: 0
Back to stocks